Celularity Inc.
CELU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5 | $6 | $11 | $18 |
| % Growth | -7.9% | -49.8% | -37% | – |
| Cost of Goods Sold | $2 | $5 | $4 | $7 |
| Gross Profit | $3 | $0 | $8 | $11 |
| % Margin | 61.8% | 8.6% | 68.9% | 59.5% |
| R&D Expenses | $5 | $3 | $4 | $4 |
| G&A Expenses | $0 | $0 | $0 | $16 |
| SG&A Expenses | $9 | $13 | $14 | $16 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $0 | $0 | $0 |
| Operating Expenses | $16 | $16 | $18 | $20 |
| Operating Income | -$13 | -$16 | -$10 | -$9 |
| % Margin | -244.1% | -276.6% | -91.8% | -51.2% |
| Other Income/Exp. Net | -$10 | -$9 | -$9 | -$4 |
| Pre-Tax Income | -$23 | -$25 | -$20 | -$13 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$23 | -$25 | -$20 | -$13 |
| % Margin | -436.7% | -427.5% | -172.9% | -73.3% |
| EPS | -0.876 | -1.021 | -0.84 | -0.595 |
| % Growth | 14.2% | -21.6% | -41.2% | – |
| EPS Diluted | -0.876 | -1.021 | -0.84 | -0.595 |
| Weighted Avg Shares Out | 26 | 24 | 24 | 22 |
| Weighted Avg Shares Out Dil | 26 | 24 | 24 | 22 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $2 | $2 | $2 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | -$20 | -$21 | -$15 | -$8 |
| % Margin | -373.4% | -361.7% | -135.5% | -41.9% |